​

Innate Pharma Ownership | Who Owns Innate Pharma?


OverviewForecastChartTranscripts

Innate Pharma Ownership Summary


Innate Pharma is owned by 0.22% institutional investors, 1.40% insiders, and 98.38% retail investors. Lion point capital, lp is the largest institutional shareholder, holding 0.09% of IPHA shares. Telescope Biotech Fund A FIL is the top mutual fund, with 0.22% of its assets in Innate Pharma shares.

IPHA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInnate Pharma0.22%1.40%98.38%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustryBiotech Stocks 180.58%11.62%-92.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Lion point capital, lp81.15K0.09%$103.87K
Morgan stanley43.52K0.05%$70.94K
Citadel advisors23.53K0.03%$45.64K
Smartharvest portfolios20.87K0.02%$34.02K
Bnp paribas arbitrage, snc11.30K0.01%$18.42K
Tocqueville asset management10.00K0.01%$16.30K
Rhumbline advisers4.72K0.01%$7.69K
Gamma investing240.000.00%$307.00
Ubs group146.000.00%$238.00
Optiver b.v.101.000.00%$197.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lion point capital, lp81.15K0.62%$103.87K
Smartharvest portfolios20.87K0.01%$34.02K
Tocqueville asset management10.00K0.00%$16.30K
Tower research capital llc (trc)---
Optiver b.v.101.00-$197.00
Steward partners investment advisory---
Barclays---
Gamma investing240.00-$307.00
Rhumbline advisers4.72K-$7.69K
Jane street group---

Top Buyers

HolderShares% AssetsChange
Citadel advisors23.53K-23.53K
Bnp paribas arbitrage, snc11.30K-11.30K
Tocqueville asset management10.00K0.00%10.00K
Caitong asset management74.00-74.00
Rhumbline advisers4.72K--

Top Sellers

HolderShares% AssetsChange
Exchange traded concepts---62.75K
Old mission capital---28.43K
Jane street group---10.31K
Millennium management---10.06K
Smartharvest portfolios20.87K0.01%-2.88K

New Positions

HolderShares% AssetsChangeValue
Citadel advisors23.53K-23.53K$45.64K
Bnp paribas arbitrage, snc11.30K-11.30K$18.42K
Tocqueville asset management10.00K0.00%10.00K$16.30K

Sold Out

HolderChange
Barclays-1.00
Tower research capital llc (trc)-3.00
Principal securities-45.00
Steward partners investment advisory-200.00
National bank of canada /fi/-450.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202610-209,5958.93%-482.39%5-2-33.33%
Jun 30, 20261011.11%192,4184.60%-519.88%5400.00%3-50.00%
Mar 31, 20266-45.45%49,212-82.19%-51.42%1-83.33%4-
Dec 31, 20257-22.22%146,38279.35%-1876.05%2-33.33%4100.00%
Sep 30, 2025928.57%81,617271.04%-12997.79%350.00%2-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Telescope Biotech Fund A FIL249.31K0.22%-
Generali France PME ETI A125.98K0.11%125.98K
Range Cancer Therapeutics ETF62.75K0.07%-
ActivePassive International Equity ETF37.49K0.05%132.00

IPHA Ownership FAQ


Who Owns Innate Pharma?

Innate Pharma shareholders are primarily institutional investors at 0.22%, followed by 1.40% insiders and 98.38% retail investors. The average institutional ownership in Innate Pharma's industry, Biotech Stocks , is 180.58%, which Innate Pharma falls below.

Who owns the most shares of Innate Pharma?

Innate Pharma’s largest shareholders are Lion point capital, lp (81.15K shares, 0.09%), Morgan stanley (43.52K shares, 0.05%), and Citadel advisors (23.53K shares, 0.03%). Together, they hold 0.16% of Innate Pharma’s total shares outstanding.

Does Blackrock own Innate Pharma?

BlackRock is not among the top 10 institutional shareholders of Innate Pharma.

Who is Innate Pharma’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Innate Pharma’s biggest shareholder by percentage of total assets invested, with 0.62% of its assets in 81.15K Innate Pharma shares, valued at 103.87K$.

Who is the top mutual fund holder of Innate Pharma shares?

Telescope Biotech Fund A FIL is the top mutual fund holder of Innate Pharma shares, with 0.22% of its total shares outstanding invested in 249.31K Innate Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools